It is a glycoprotein hormone that controls the production of red blood cells, or the production of red blood cells.
This report contains market size and forecasts of Erythropoietin (EPO) Drugs in Global, including the following market information:
Global Erythropoietin (EPO) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erythropoietin (EPO) Drugs market was valued at 9422.9 million in 2021 and is projected to reach US$ 13650 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epoetin-alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin (EPO) Drugs include Pfizer, Roche, Amgen, Johnson & Johnson, Kyowa Kirin, Shanghai Dahua Pharmaceutical, JCR Pharmaceuticals and Teva Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin (EPO) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin (EPO) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, by Type, 2021 (%)
Epoetin-alfa
Darbepoetin-alfa
Global Erythropoietin (EPO) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Erythropoietin (EPO) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythropoietin (EPO) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erythropoietin (EPO) Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Amgen
Johnson & Johnson
Kyowa Kirin
Shanghai Dahua Pharmaceutical
JCR Pharmaceuticals
Teva Pharmaceuticals